Top Markets
Coin of the day
Advanced Proteome Therapeutics Corporation Advanced Proteome Therapeutics Corporation

Advanced Proteome Therapeutics Corporation

APTCF
Rank in Stocks #40426
Advanced Proteome Therapeutics Corporation, operating through its subsidiary... Advanced Proteome Therapeutics Corporation, operating through its subsidiary Advanced Proteome Therapeutics Inc., functions as a biotechnology company based in the United States. Its core business involves the creation and commercialization of a unique platform designed for the chemical modification of protein-based treatments. This proprietary technology is applied across several domains, specifically antibody-drug conjugates, broader protein conjugates, and approaches to immunomodulation. The company's corporate base is in Burnaby, Canada.
Share Price
$0.0002
Last synced: 2025-05-15
Market Cap
$149.63K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
CA
Trade Advanced Proteome Therapeutics Corporation (APTCF)

Category

P/S ratio for Advanced Proteome Therapeutics Corporation (APTCF)
P/S ratio as of 2026 TTM: 0
According to Advanced Proteome Therapeutics Corporation latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Advanced Proteome Therapeutics Corporation from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
9.88 -
US
10.30 -
NL
- -
CH
- -
KR
4.98 -
BE